CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Newron Pharmaceuticals Spa Company Snapshot
Newron Pharmaceuticals Spa operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Newron Pharmaceuticals Spa with three other miscellaneous service companies in Europe: MaxCyte Inc of the United Kingdom (2017 sales of £10.74 million [US$15.41 million] ), GeNeuro SA of France (14.95 million Euro [US$18.50 million] ), and Oncodesign Sa which is also based in France (14.41 million Euro [US$17.83 million] ).

Sales Analysis. Sales increased substantially in 2017: During the year ended December of 2017, sales at Newron Pharmaceuticals Spa were 13.29 million Euro (US$16.44 million). This is an increase of 180.5% versus 2016, when the company's sales were 4.74 million Euro. This was the third consecutive year of growth at Newron Pharmaceuticals Spa.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Newron Pharmaceuticals Spa
  Stock Performance Chart for Newron Pharmaceuticals Spa
 
  Stock Data: Recent Stock Performance:
  Current Price (4/13/2018): 7.11
(Figures in Euro)
1 Week -8.2%   13 Weeks -7.8%  
4 Weeks -30.6%   52 Weeks -66.5%  
 
Newron Pharmaceuticals Spa Key Data:
  Ticker: NWRN Country: Italy
  Exchanges: ZHR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 13,285,000
(Year Ending Jan 2018).
Employees: 1
  Currency: Euro Market Cap: 126,763,233
  Fiscal Yr Ends: December Shares Outstanding: 17,837,345
  Share Type: Azioni Ordinaire Closely Held Shares: 3,659,923
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.